Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion type Assertion NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_head.
- NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion description "[We investigated the effect of a concomitant treatment of ICI 164384 and B-interferon (beta-IFN) on the growth of estrogen-receptor-positive (ER+) and estrogen-receptor-negative (ER-) breast cancer cell lines and on their steroid receptor profiles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_provenance.
- NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion evidence source_evidence_literature NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_provenance.
- NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion SIO_000772 8669823 NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_provenance.
- NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion wasDerivedFrom befree-20150227 NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_provenance.
- NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_assertion wasGeneratedBy ECO_0000203 NP478835.RABQqxCSE6hf5iFvYxyCdknfo-01pgD4D6nSQIu9mpdfc130_provenance.